Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1
2021 · Acta Pharmaceutica Sinica B · 345 citations
https://doi.org/10.1016/j.apsb.2021.12.007
F
Fei Xia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
112
Papers
2.0K
Citations
23
h-index
42
i10-index
Fei Xia is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Food Allergy and Anaphylaxis Research & Allergic Rhinitis and Sensitization & Cancer-related molecular mechanisms research. The author has an h-index of 23, co-authored 96 publications.
ORCID: 0000-0001-9131-8417Papers by this author
worksAdvanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
2023 · Research · 160 citations
https://doi.org/10.34133/research.0148
Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines
2023 · Journal of Nanobiotechnology · 63 citations
https://doi.org/10.1186/s12951-023-02165-x
Discovery and repurposing of artemisinin
2022 · Frontiers of Medicine · 62 citations
https://doi.org/10.1007/s11684-021-0898-6
18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs
2022 · Journal of Pharmaceutical Analysis · 48 citations
https://doi.org/10.1016/j.jpha.2022.06.001
A highly efficient protein corona-based proteomic analysis strategy for the discovery of pharmacodynamic biomarkers
2022 · Journal of Pharmaceutical Analysis · 42 citations
https://doi.org/10.1016/j.jpha.2022.07.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat